Hakan Atas, Buket Altun Ozdemir, Bulent Comcal

How should normocalcemic primary hyperparathyroidism be managed? Comparison with classical hypercalcemic form

Aim: Normocalcemic primary hyperparathyroidism (N-PHPT) is a different variant of primary hyperparathyroidism characterized by normal serum calcium (Ca) concentrations and elevated parathormone (PTH) levels in the absence of secondary causes of hyperparathyroidism. However, the clinical course and therapeutic approaches of this entity have been not fully demonstrated. We aimed to determine the clinicopathological characteristics and surgical outcomes of patients with N-PHPT, comparing with patients who had hypercalcemic PHPT (H-PHPT). Materials and Methods: A total of 185 patients who underwent parathyroidectomy for PHPT were included in the study. The patients were classified as N-PHPT and H-PHPT. The two groups were then compared between each other in terms of all demographic, clinical, and surgical features. Results: One hundred and fifty-one (81.6%) patients had a diagnosis of H-PHPT while 34 (18.4%) patients were normocalcemic. Both groups were similar in age, preoperative vitamin D level, preoperative PTH level, and type of surgery (p > 0.05). Preoperative Ca level was significantly different between the groups (p < 0.01). Prevalence of urolithiasis and decreased bone density was similar between the groups (p > 0.05). Conclusion: N-PHPT patients had similar demographic and clinical features in comparison to those with H-PHPT, indicating that the surgical decision in patients with N-PHPT should be similar with H-PHPT cases.

PDF

___

1. Chen G, Xue Y, Zhang Q, et al. Is normocalcemic primary hyperparathyroidism harmful or harmless? J Clin Endocrinol Metab 2015;100:2420-4.
2. Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. Bone Reports 2014;99:3561-9.
3. Eastell R, Brandi ML, Costa AG, et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 2014;99:3570-9.
4. Pawlowska M, Cusano NE. An overview of normocalcemic primary hyperparathyroidism. Curr Opin Endocrinol Diabetes Obes 2015;22:413-21.
5. Šiprová H, Fryšák Z, Souček M. Primary hyperparathyroidism, with a focus on management of the normocalcemic form: to treat or not to treat? Endocr Pract 2016;22:294-301.
6. Gómez-Ramírez J, Mihai R. Normocalcaemic primary hyperparathyroidism: a diagnostic and therapeutic algorithm. Langenbecks Arch Surg 2017;402:1103-8.
7. Cusano NE, Silverberg SJ, Bilezikian JP. Normocalcemic primary hyperparathyroidism. J Clin Densitom 2013;16:33-9.
8. Cusano NE, Maalouf NM, Wang PY, et al. Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations. J Clin Endocrinol Metab 2013;98:2734-41.
9. Tuna MM, Caliskan M, Unal M, et al. Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism. J Bone Miner Metab 2016;34:331-5.
10. Pierreux J, Bravenboer B. Normocalcemic Primary Hyperparathyroidism: A comparison with the hypercalcemic form in a tertiary referral population. Horm Metab Res 2018;50:797-802.
11. Silverberg SJ, Bilezikian JP. “Incipient” primary hyperparathyroidism: a “forme fruste” of an old disease. J Clin Endocrinol Metab 2003;88:5348-52.
12. Marques TF, Vasconcelos R, Diniz E, et al. Normocalcemic primary hyperparathyroidism in clinical practice: an indolent condition or a silent threat? Arq Bras Endocrinol Metabol 2011;55:314-7.
13. Amaral LM, Queiroz DC, Marques TF, et al. Normocalcemic versus hypercalcemic primary hyperparathyroidism: more stone than bone? J Osteoporos 2012;2012:128352.
14. Yener Ozturk F, Erol S, Canat MM, et al. Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patients. Endocr J 2016;63:111-8.
15. Koumakis E, Souberbielle JC, Sarfati E, et al. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism. J Clin Endocrinol Metab 2013;98:3213-20.
16. Spivacow FR, Durán AS, Zanchetta MB. Hiperparatiroidismo primario normocalcémico. Medicina (Buenos Aires) 2014;74:457-61.
17. Schini M, Jacques RM, Oakes E, et al. Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History. J Clin Endocrinol Metab 2020;105:1171-86.
18. Lowe H, McMahon DJ, Rubin MR, et al. Normocalcemic primary hyperparathyroidism: Further characterization of a new clinical phenotype. J Clin Endocrinol Metab 2007;92:3001-5.
19. Garcia-Martin A, Reyes-Garcia R, Munoz-Torres M. Normocalcemic primary hyperparathyroidism: Oneyear follow-up in one hundred postmenopausal women. Endocrine 2012;42:764-6.